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Abstract
Achieving the vision of identifying and quantifying cancer-related events and targets for future 
personalized oncology is predicated on the existence of synthetically accessible and economically 
viable probe molecules fully able to report the presence of these events and targets in a rapid, and 
highly selective and sensitive fashion. Delineated here are the design and evaluation of a newly 
synthesized turn-on probe whose intense fluorescent reporter signature is revealed only through 
probe activation by a specific intracellular enzyme present in tumor cells of multiple origins. 
Quenching of molecular probe fluorescence is achieved through unique photo-induced electron 
transfer (PeT) between the naphthalimide dye reporter and a covalently attached, quinone-based 
enzyme substrate. Fluorescence of the reporter dye is turned on by rapid removal of the quinone 
quencher, an event that immediately occurs only after highly selective, two-electron reduction of 
the sterically and conformationally restricted quinone substrate by the cancer-associated human 
NAD(P)H:quinone oxidoreductase isozyme 1 (hNQO1). Successes of the approach include rapid 
differentiation of NQO1-expressing and non-expressing cancer cell lines via the unaided eye, flow 
cytometry, fluorescence imaging, and two-photon microscopy. The potential for use of the turn-on 
probe in longer-term cellular studies is indicated by its lack of influence on cell viability and its in 
vitro stability.
INTRODUCTION
Molecular probes whose fluorescent reporter signal is generated (turn-on probes) by enzyme 
activation1 hold great potential for identification, enumeration, and study of living cancer 
cells—outcomes invaluable for accurate and early diagnoses and optimization of surgical 
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and personalized chemotherapeutic treatments.2,3 In particular, the successful development 
of enzyme-activatable probes that can yield rapid, and highly sensitive and selective, 
reporting of species or events associated with cancer cells4–6 will allow for definition of 
diseased and healthy tissue borders during fluorescence-assisted surgical resection of 
cancerous tissues and collection of real-time information on tumor cell microenvironment or 
the pharmacodynamic effect of drugs on specific tumor cells.3,5–13 To date, live cancer cell 
detection with varying degrees of selectivity and sensitivity has been limited to routes 
employing extracellular or cell-surface protein recognition of a covalently attached 
component of the probe or reporter.3,12,14 However, successful identification of living 
cancer cells and their type differentiation can be achieved by targeting endogenous, 
intracellular, cancer-associated enzymes with hydrophobic small-molecule (<1000 Da), 
turn-on probes, an outcome not possible with large-molecule, recognition-based probes.
A potentially significant and unexplored route with turn-on probes for diagnostics is that in 
which selectivity and sensitivity of the target reporting process are controlled by 
enzymatically stimulated removal of fluorescence quencher from the probe. In particular, 
this route employs probes whose reporter fluorescence is quenched by photo-induced 
electron transfer (PeT)15 from a covalently attached enzyme substrate. Fluorescence ensues 
from the reporter upon removal of the quencher substrate by an endogenous, cytosolic, 
disease-associated enzyme found in diseased cells from a wide range of origins.
NAD(P)H:quinone oxidoreductase isozyme 1 (NQO1)16–19 is intimately involved with 
cancer, as it is a gatekeeper for the 20S proteasomal degradation of the p53, p73α, and p33 
tumor suppressors16 and is present in a diverse group of human tumor cells (e.g., pancreas, 
colon, breast, lung, liver, stomach, kidney, head/neck, and ovaries) at levels 2- to 50-fold 
greater than in normal tissue.17 Furthermore, NQO1 content/activity in tumor cells is 
strongly affected by cell life cycle and therapeutic approaches.18–20 Importantly, NQO1 is 
found in the cytosol and catalyzes the strict two-electron reduction of quinones to 
hydroquinones, making this flavoenzyme an ideal target for pro-drug therapies21 and pro-
fluorophores.
Herein we report the design, properties, and NQO1-specific cellular activation of a first-
generation, PeT-quenched fluorescence probe. The turn-on sensor probe readily penetrates 
the membrane of human cancer cells, because it is hydrophobic, small in molecular weight, 
and charge neutral. Upon rapid and preferential, two-electron reduction of the quinone 
quencher subunit of the turn-on probe, an intensely light-emissive reporter results from 
autonomous removal of the activated quinone subunit. Efficacious PeT quenching of 
fluorescence prior to subunit self cleavage is ensured by careful selection of the electronic 
properties of the naphthalimide reporter and quinone quencher. The resulting highly 
fluorescent, cationic reporter is retained by cells, and it exhibits a strong Stokes shift 
between its absorption and fluorescence emission maxima due to the push-pull internal 
charge transfer mechanism associated with the naphthalimide scaffold. Overall, these probe 
characteristics allow for rapid and enhanced signal-to-background imaging and detection of 
living cancer cells without the typical requirement of unactivated probe removal from the 
environment. In total, the pro-fluorogenic probe provides for real-time, highly sensitive and 
selective human tumor cell analysis and differentiation based on NQO1 content.
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Q3NI Probe Fluorescence is Controlled by Photo-induced Electron Transfer (PeT) 
Quenching
We designed the Q3NI probe to have the fluorescence signal of its naphthalimide 
reporter22,23 quenched via oxidative electron-transfer (OeT) by the covalently attached 
quinone propionic acid motif, Figure 1A. It was posited that it would be possible to achieve 
this novel mechanism of reporter quenching by carefully tuning the electronic and optical 
properties of the quinone OeT quencher and the naphthalimide reporter NI, due to extant 
naphthalimide reporters that are quenched by reductive electron-transfer (ReT).22 The 
Rehm-Weller equation, Equation 1,
(1)
was used to examine possible quinone propionic acid quenchers24 and 1,8-naphthalimide 
reporters, as well as linkers between the OeT quencher and the NI reporter, so as to ensure 
that quenching is thermodynamically feasible and efficient.15 In this equation, ED is the 
redox potential of the donor and EA that of the acceptor, ΔG00 is the energy of the first 
excited singlet state of the reporter, and e2/εd is the Coulombic interaction energy of the ion 
pair, known to be 0.06 eV.15 The energy of the first excited singlet state of NI was measured 
to be 3.06 eV.15 From voltammetric measurements, ED of NI was determined to be 1.74 V, 
and EA for the quinone propionic acid group of Q3NI was found to be −1.01 V (Figure S2). 
From these values, the energy change for this OeT process, ΔGPeT, is calculated to be −0.37 
eV, indicating that electron transfer from the excited dye to the electron-poor quinone is 
thermodynamically favorable. The quinone was attached to the naphthalimide via an N-
methylethanolamine linker through a carbamate to the amine of the naphthalimide ring. This 
linker imparts three crucial properties on Q3NI: the linker is sufficiently short to allow for a 
high probability of electron transfer, the electron-withdrawing carbamate yields a favorable 
ΔGPeT, and the presence of the tertiary amide provides enhanced environmental 
stability.23,25 As a result, the fluorescence of Q3NI in pH 7.4, 0.1 M PBS is effectively 
quenched in comparison to that of the free NI reporter, as noted by their spectra in Figure 
1B and 1C and respective fluorescence quantum yields (Φ) of 0.007 and 0.23 obtained using 
quinine sulfate as standard.26 The quantum yield for NI is superior or comparable to that of 
other dyes applied to cancer detection and localization, such as Φ = 0.0028 for indocyanine 
green and Φ = 0.21 for Cy5.5 dyes.13,27 The 33-fold fluorescence enhancement for NI 
versus Q3NI and very large Stokes shift of 116 nm (λmax, abs = 374 nm, λmax, em = 490 nm) 
bode well for use of Q3NI as a multifunctional turn-on probe for sensing and imaging 
applications that utilize reductive stimuli capable of initiating removal of the reduced 
quinone group.28–31
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Fluorescence Dequenching of Q3NI is Achieved by Reduction-initiated Removal of 
Quinone
We then wished to determine if it is possible to produce the NI reporter from the Q3NI 
probe by the expected cyclizative cleavage reaction of the hydroquinone via the gem-dialkyl 
effect32 that occurs subsequent to two-electron reduction of the quinone.28 Thus, the strong 
reducing agent sodium dithionite was added to aqueous solutions of Q3NI. Under these 
conditions, it was found that NI is rapidly released as indicated by the increase in time-
dependent fluorescence intensity (Figure 2) at 470 nm (λex = 370 nm). To provide proof 
positive that the increase in fluorescence for reduced Q3NI results from cyclizative cleavage 
of the hydroquinone reduction product as the lactone, a second probe (Q1NI) was 
synthesized such that the rate of lactone formation from its hydroquinone form is >103 times 
slower than in the case of reduced Q3NI, due to the lack of the two methyl groups on the 
geminal carbon.28 Dithionite reduction of the Q1 group is known to be equally fast as the Q3 
group.28 As seen in Figure 2, reduced Q3NI exhibits exceedingly rapid NI reporter 
production in comparison to reduced Q1NI; at 37 min (the maximum recorded for Q3NI), 
the signal for reduced Q3NI is 20-fold higher than that for Q1NI. Although it could be 
argued the signal for reduced Q3NI is attributable to the absence of photo-induced electron 
transfer quenching of the reporter by the hydroquinone of Q3NI, a significantly favorable 
ΔGPeT of −3.37 eV for the reductive quenching process of the NI reporter by the 
hydroquinone clearly supports its occurrence. That is, once the quinone is reduced to its 
hydroquinone (HQ3NI, Figure 1A), quenching of reporter fluorescence occurs by reductive 
electron transfer (ReT), a common feature with naphthalimide dyes.22 Furthermore, we have 
isolated and identified the NI reporter from Q3NI solutions treated with dithionite (Figure 
S-6). Thus, the rapid increase in fluorescence for reduced Q3NI results from naphthalimide 
dequenching caused by reduction-initiated removal of the quinone propionic acid group by 
lactonization. Due to the unique quenching mechanism of the Q3NI turn-on probe sensor, 
pronounced fluorescence signal enhancement upon revealing the NI reporter and its large 
Stokes shift, and the known resistance of the quinone propionic acid trigger group to 
reduction by other biological species,31 we investigated Q3NI as a sensor probe of human 
NAD(P)H:quinone oxidoreductase isozyme 1 (hNQO1) activity in real-time biological 
applications.
Q3NI is Activated by hNQO1 at a High Rate
We determined if Q3NI is a substrate capable of activation by hNQO1 to yield the NI 
reporter at a significant rate. To do so, we obtained the apparent kinetic parameters from 
Michaelis-Menten kinetic treatment33 of the time-dependent NI reporter production, namely 
the Michaelis constant (Km), maximum velocity (Vmax), catalytic constant (kcat), and 
substrate specificity (kcat/Km). The high rate of NI reporter production under in vitro 
conditions is readily apparent in the inset of Figure 3; after 5 min, a fluorescent signal has 
been attained that is 22% of the maximum achievable, yielding 2.2 × 10−7 M of released 
reporter. From the plot shown in Figure 3, we obtained Km = 3.86 ± 0.79 μM, Vmax = 0.037 
± 0.002 μmol min−1mg · NQO1−1, kcat = 0.019 ± 0.001 s−1, and kcat/Km = 4.94 ± 0.33 × 103 
M−1s−1. Due to the presence of the non-bulky ethanolamine linker and the need of only a 
single activation step to reveal reporter fluorescence, the kinetic constants are significantly 
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higher than those of other NQO1 activatable fluorophores,31,34,35 thereby ensuring sufficient 
signal enhancement for fast detection of hNQO1 activity.
Cancer Cells can be Rapidly Visualized and Differentiated Based on hNQO1 Activation of 
Q3NI
Our interest in the potential use of the Q3NI probe in microfluidic-based cell sorting/
isolation of circulating tumor cells36 and fluorescence-guided resection of tumors3 led us to 
evaluate if the Q3NI probe can be used to discriminate between cancer cells of different 
origins and hNQO1 content, with and without the aid of sophisticated instrumentation. The 
colorectal carcinoma cell line HT-29 and the non-small cell lung cancer (NSCLC) A549 cell 
line are known to possess significant hNQO1 activity, while the NSCLC H596 cell line has 
been reported to have undetectable hNQO1 activity.37,38 After a 10-min incubation period in 
a cell culture solution containing 2 × 10−5 M Q3NI, it was possible to differentiate between 
the various substrate-cultured cells (4.84 cm2) using only a hand-held fluorescent lamp 
emitting at 365 nm and the un-aided eye (Figure 4). Both HT-29 (3.69 × 106 total cells) and 
A549 (5.72 × 106 total cells) appeared fluorescent blue, while H596 (3.96 × 106 total cells) 
exhibited no apparent emission. The ability to visually determine the presence of hNQO1 in 
a small number of cells is due to the marked difference in fluorescence from the unquenched 
NI reporter (Φ = 0.23) and quenched Q3NI probe (Φ =0.007) and the large Stokes shift of 
the NI reporter that results in fluorescence emission in the visible spectrum (400 nm to ~600 
nm). These outcomes point to potential use of the Q3NI probe sensor in the real-time, 
visible (without the aid of imaging equipment) and accurate determination of tumor/healthy 
tissue borders so as to allow for surgical resection of tumors with small foci.
Flow cytometry assays (Figure 5) were used to assess the applicability of the Q3NI probe to 
rapidly detect and quantify tumor cells containing hNQO1. The probe was incubated in a 
suspension of HT-29, A549, H596, and H446 (a small cell lung carcinoma known to be 
devoid of hNQO1 activity37) cells for either 10 or 60 min, and a flow cytometer was used to 
measure the fluorescence (λex = 405 nm, λem = 457/60 nm) in 10,000 individual cells. In 
Figure 5 are shown the histograms for each cancer cell line. It is clear that a high-intensity, 
unimodal distribution of signals is obtained for Q3NI activation in each of the two hNQO1-
positive cell lines (HT-29 and A549), while the negative cell lines H596 and H446 produced 
minimal fluorescence. It was also found that there was little change in the cell count or 
intensity of the histograms for a longer probe incubation time (60 min vs. 10 min, Figure 
S3), demonstrating the rapid and substantial activation of Q3NI in A549 and HT-29 cells. 
Importantly, the sustained low fluorescence observed with the H446 cells (Figure S3) points 
to the intracellular stability of Q3NI (lack of non-specific activation). Thus, it is indicated 
that Q3NI is a highly sensitive and selective probe capable of being used to rapidly discern 
different types of tumor cells in fluidic streams.
Live and Fixed hNQO1-containing Cancer Cells can be Selectively Imaged via Q3NI 
Activation
We desired to know if cancer cell types can be differentiated in conventional fluorescence 
microscopy images resulting from Q3NI activation by hNQO1, and if it is possible to obtain 
images that allow collection of information regarding the fate of the released NI reporter. 
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Furthermore, we wished to learn if the NI reporter can be successfully used in upconversion 
fluorescence (multi-photon) imaging of live cells.13 In agreement with flow cytometry data, 
wide-field imaging of fixed hNQO1-positive cells exposed to the Q3NI probe for 10 min 
revealed significant probe uptake and activation that leads to intracellular NI fluorescence 
for the A549 and HT-29 cell lines; however, minimal signal was observed in the hNQO1-
negative H596 cells (Figure S4). There was no indication of reporter in the nucleus, pointing 
to the lack of NQO1 there; this is in clear contrast to previous work using 
immunohistochemical staining of permeabilized, fixed cells.39 The average cytosolic signal 
was 9 times higher in A549 cells versus NQO1-negative H596 cells, while it was 23 times 
higher in HT-29 cells compared to the NQO1-negative H596 cells. After incubating live 
HT-29 cells for 20 min with Q3NI followed by exposure to acidic organelle-specific 
Lysotracker Red in the media in the imaging dish, it was found that the majority of the NI 
signal originated from the cytosolic region. Not surprisingly, accumulation of the basic 
(secondary amine pKa ~11) NI occurred in acidic late endosomal and lysosomal vesicles 
(Figure S5), a beneficial outcome that leads to enhanced intracellular retention of NI. The 
higher signal-to-background value achieved for activation of Q3NI to NI reporter (9- to 23-
fold) in target versus non-target cells, relative to that of other exogenously introduced sensor 
probes for whole tumor analysis (2.5- to 5-fold),40–42 points to the potential of Q3NI to 
provide highly selective tumor cell analyses with low limits of detection, even in the face of 
possible background fluorescence from hemoglobin and other species.1 In addition, our 
results indicate that dye quantum yield is affected little, and there is no apparent efflux of NI 
reporter from cells during paraformaldehyde fixing, as noted by sustained fluorescence in 
fixed samples stored for 10 months in the laboratory ambient. Collectively, there is great 
potential for use of our probe/reporter system for ex vivo quantitative analysis of excised 
tumor cells and long-term in vivo and in vitro imaging.
Multiphoton (MP) microscopy imaging of cells and tissues is more advantageous when 
compared to traditional fluorescence microscopy, because use of the characteristic long-
wavelength photons offers higher fluorophore and cellular photostability that provides 
extended imaging duration, less background signal from out-of-focus excitation and 
scattering events, and deeper penetration depth. In addition, MP imaging is ideal for direct 
observation of targets in their physiological environment and ex vivo thick-specimen 
sampling where 2D and 3D maps can be generated.13 During incubation with complete 
growth medium containing 2.0 × 10−5 M Q3NI, 2-photon microscopy revealed significant 
fluorescence signal from NI in living, hNQO1-positive HT-29 and A549 cells (Figure 6) and 
minimal signal in two living, hNQO1-negative cell lines, H596 and H446. The average 
fluorescence signal was determined to be 13-fold higher in A549 cells compared to H596 
cells, and 3.66 × 104-fold higher versus H446 cells. Similar results were obtained with the 
HT-29 cell line, with the cytosolic intensity being 15- and 4.51 × 104-fold higher compared 
to H596 and H446 cells. As before, the signal appears somewhat heterogeneous throughout 
the cytosolic space of the HT-29 and A549 cells due to NI accumulation in acidic 
organelles. To ensure Q3NI and NI had little effect on cell health, cells were incubated in a 
2.0 × 10−5 M Q3NI solution in complete growth medium for one hour and one day, and then 
cell viability was assessed with a trypan blue assay. After 1 h, cell viability for HT-29, 
A549, and H596 was 97.7%, 98.8%, and 100%, while it was 97.7%, 98.7%, and 98.4% after 
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24 h. Of particular importance is the real-time nature of the Q3NI probe in imaging, as this 
system does not require the time-consuming wash steps characteristic of always-on 
reporters.1,4
CONCLUDING REMARKS
In summary, we have presented the successful development and implementation of a 
quenched turn-on probe whose fluorescent reporter signal is selectively and quickly 
generated and maintained in human cancer cells upon activation by a cancer-associated-
enzyme substrate that is subsequently removed from the probe to yield the free de-quenched 
reporter dye. Specifically, intracellular reduction of the quinone substrate by 
NAD(P)H:quinone oxidoreductase and successive self-removal of the reduced substrate 
from the reporter leads to elimination of the photo-induced electron-transfer quenching 
event, thereby yielding the naphthalimide reporter possessing a highly intense and Stokes-
shifted emission. As a result, we have achieved rapid and highly selective/sensitive 
detection, differentiation, and enumeration of cancer cells in flowing streams and under 
traditional microscopy conditions without the use of recognition agents, an outcome that has 
in turn allowed for imaging of live cancer cells by multi-photon fluorescence microscopy. 
The latter outcome bodes well for in vivo and ex vivo thick-specimen imaging, where the 
efficacy of treatment protocols and the cellular impact of pharmaceutical targets can be 
evaluated for personalized oncology. Finally, control over the emission characteristics of the 
reporter dye22 coupled to our ability to visibly see, by the un-aided eye, relatively small 
numbers of cancer cells, reveals the potential of this new class of probes for application to 
fluorescence-guided surgical resection of cancerous tissues.
EXPERIMENTAL
Full details regarding materials, synthesis of compounds, and their characterization are 
described in the Supporting Information.
Cell Culture
HT-29 (human colorectal adenocarcinoma), A549 (human non-small cell lung cancer, 
NSCLC), H596 (human NSCLC), and H446 (human small-cell lung cancer) were all 
purchased from American Type Cell Culture. HT-29 cells were cultured in McCoy’s 5A 
medium supplemented with 10% fetal bovine serum (FBS) and 100 IU/mL penicillin-
streptomycin, A549 cells were cultured in F-12K medium with 10% FBS and 100 IU/mL 
penicillin-streptomycin, and H596/H446 were cultured in RPMI-1640 with 10% FBS and 
100 IU/mL penicillin-streptomycin. Cells were incubated at 37 °C in a humidified incubator 
containing 5% wt/vol CO2.
Flow Cytometry
To a 1-mL suspension of cells (1 × 106) in complete growth medium was added Q3NI from 
a stock dimethylsulfoxide (DMSO) solution to give a final [Q3NI] = 2 × 10 −5 M and 
[DMSO] ~1%. After 10- or 60-min incubations at 37 °C, the cells were fixed with 30 mL of 
4% paraformaldehyde in 0.1 M PBS for 1 h, followed by washing twice with 0.1 M PBS, 
and then resuspending in 1 mL PBS. Data acquisition was carried out on an iCyt Reflection 
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flow cytometer using 405-nm excitation and a 457/60 nm emission filter; logarithmic 
amplification was used. Winlist software (Verity Software House, Topshame, ME) was used 
to count 10,000 cells per sample; FlowJo software was used to construct histograms.
Enzyme Kinetics
All fluorescence measurements (λex = 390 nm, λem = 470 nm) were obtained at room 
temperature, with solutions composed of pH 7.4, 0.1 M PBS/0.1 M KCl/0.007% BSA. A 
stock solution of 1 × 10 −4 M β-nicotinamide adenine dinucleotide, reduced disodium salt 
(NADH, Sigma-Aldrich), was made with the PBS buffer; this NADH solution was 
subsequently used to prepare all other solutions so as to have a final concentration of 1 × 
10 −4 M β-NADH in each assay. Solutions consisting of 2 × 10 −6 to 6 × 10 −5 M Q3NI were 
made using the NADH stock. A 1.33 μg/mL stock solution of recombinant human NQO1 
(Sigma-Aldrich) was prepared using the same buffer as above so as to give 2.0 × 10−5 g 
hNQO1 per assay. Each assay was performed in a quartz fluorescence cuvette containing 1.5 
mL Q3NI solution and initiated by the addition of 1.5 mL hNQO1 solution. Measurements 
were collected every 30 s for 5 min. Fluorescence units were converted to concentration by 
relating the signal increase to a fluorescence signal derived from a known concentration of 
NI. Plots of velocity versus Q3NI concentration were used to obtain apparent Km and Vmax 
values from non-linear least squares analysis employing algorithms developed by Cleland 
for Michaelis-Menten kinetics.33
Cell Viability
Cells were cultured in 5 mL of complete growth medium in a sterile tube. To the medium 
was added Q3NI (from a 1.8 × 10−3 M stock solution) in DMSO, to give a 2.0 × 10−5 M 
Q3NI solution, and the cells were incubated at 37 °C, 5% CO2 for 1 h or 24 h, after which 1 
mL of the cell suspension was removed and then 0.1 mL trypan blue was added. Cells were 
immediately counted using a hemocytometer and microscope.
Optical Differentiation
HT-29, A549, and H596 cells were cultured overnight on 2.2 × 2.2 cm glass cover slips. Old 
growth medium was removed and replaced with a 2.0 × 10−5 M Q3NI solution in fresh 
growth medium. Cells were incubated at 37 °C with Q3NI for 10 min and then rinsed with 
0.1 M PBS. Cover slips of each cell line were immediately placed upside down on glass 
slides and visualized with a Kodak digital camera in conjunction with a Mineralight Model 
UVGL-25 lamp (365 nm, 0.16 amps, 60 Hz).
Confocal Colocalization
Confocal fluorescence images were acquired with a Leica TCS SP5 tandem scanning 
multiphoton laser scanning microscope using a 40x oil immersion objective lens (1.25 NA). 
Imaging of Lysotracker Red- and Q3NI-exposed cells was accomplished using a sequential 
scanning method with λex = 405 nm at 10% output and collecting emission between 417 and 
467 nm (Q3NI) or λex = 561 nm at 10% output, and the emitted light was collected between 
574 and 621 nm (Lysotracker Red). Differential interference contrast (DIC) images were 
obtained using a PMT detector and 633-nm light at 3% output as an illumination source. All 
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images were collected at 37 °C using the Leica TCS SP5 in resonant scanning mode (16 
KHz) at a zoom setting of 3.6. Images were line averaged 64 times. Cells were cultured 
overnight in black 35 × 10 mm, 22-mm well, glass-bottom dishes (Chemglass Life 
Sciences). Prior to imaging, the medium was removed and replaced with medium 
(containing no phenol red) and maintained at 37 °C. A concentrated solution of Q3NI in 
DMSO was added directly to the dish to give a concentration of 2.0 × 10−5 M, with [DMSO] 
≤ 1%. Cells were incubated with Q3NI for 20 min. Five min prior to imaging, Lysotracker 
Red-DND 99 in DMSO was added to give a concentration of 1 × 10−7 M.
In vitro 2-Photon Imaging
Two-photon confocal fluorescence images were acquired as above using a MaiTai two-
photon laser tuned to 750 nm (3% laser power, modelocked Ti:sapphire laser; Tsunami 
Spectra Physics), and emission was collected using a short-pass 680-nm filter. DIC images 
were collected as above. Cells were imaged, with no washing or medium removal steps, 
after a 10-min incubation with Q3NI. Image analysis was performed in ImageJ.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Schematic representation of the unique utilization of PeT quenching in the hNQO1 probe 
Q3NI and the emission properties associated with Q3NI probe and NI: (A) proposed 
quenching mechanisms for Q3NI probe prior to and after chemical/hNQO1-catalyzed 
reduction, and subsequent production of the fluorescent NI reporter. Fluorescence spectra 
and optical images of cuvettes containing 2.0 × −6 M solutions of (B) Q3NI probe and (C) 
NI reporter in pH 7.4, 0.1 M PBS that result from excitation at λex = 375 nm (spectra) and 
λex = 365 nm (images).
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Comparing the dithionite-initiated formation of NI reporter from Q3NI probe and Q1NI. 
The fluorescence (λex = 370 nm, λem = 470 nm) from 3-mL solutions of 1.0 × 10−5 M Q3NI 
probe and Q1NI in pH 7.4, 0.1 M PBS was monitored after their reduction by addition of 
2.75 mg sodium dithionite (denoted by arrow).
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Kinetics plot of hNQO1 (2.0 × 10−5 g) toward Q3NI Probe. Inset is an example of an assay 
observing fluorescent NI production from 1 × 10−6 M Q3NI, relative to signal for complete 
NI formation (1 × 10−6 M). Values (n = 3) are the average ± 1 standard deviation.
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Visual differentiation of (A) HT-29, (B) A549, and (C) H596 cancer cells cultured on 2.2 × 
2.2 cm glass substrates after 10-min incubation with 2 × 10−5 M Q3NI probe. Images of 
cells were captured with a digital camera upon irradiation at λex = 365 nm with a hand-held 
lamp. Scale bar represents 1 cm.
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Flow cytometry assays of Q3NI activation by hNQO1-positive (A549 and HT-29) and 
hNQO1-negative (H596 and H446) cancer cells. Assays were performed by counting 10,000 
cells that had been exposed to 2.0 × 10−5 M Q3NI probe for 10 min; λex = 405 nm, λem = 
457/60 nm.
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Two-photon confocal microscopy imaging of living HT-29 (A,E), A549 (B,F), H596 (C,G), 
and H446 (D,H) cells in the presence of 2.0 × 10−5 M Q3NI probe. Fluorescence images of 
each cell line are on the top row with their respective differential interference contrast (DIC) 
image on the bottom row. Images were acquired at λex = 750 nm (3% laser power) without 
any washing steps between Q3NI probe addition and imaging. Scale bars represent 2.5 × 
10−5 m.
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